***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***
The content of this online activity was originally presented as part of a live event. It is divided into three videos. Learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.
The North American Thrombosis Forum's (NATF’s) "United States CTEPH Proceedings 2021" provides a multidisciplinary framework for the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). The activity is comprised of didactic presentations, debates, and panel discussions involving national and international experts in the field.
Covered topics in the series will include:
This activity has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, interventional cardiologists and radiologists, anesthesiologists, thoracic radiologists, nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with CTEPH.
Supported by educational grants from: Abbott Laboratories; Acceleron Pharma Inc.; Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; and Boston Scientific Corporation.
This internet enduring material activity is part of a series of activities. Participation in this activity is free of charge.
Release Date: December 15, 2021 -- Expiration Date: December 14, 2022
Faculty: Multiple Faculty,
Nonsurgical Management of CTEPH: Medical
Inoperable CTEPH: Defining the Role of Medical Treatment Alison Witkin, MD
The Hematology of CTEPH: Perioperative Considerations Richard Channick, MD
Post-PTE Anticoagulation, Warfarin vs. DOACs: End of the INR? Ivan Robbins, MD
Life After PTE: Residual PH Assessment and Mechanical VTE Risk Mitigation Anjali Vaidya, MD, FACC, FASE, FACP
Balloon Pulmonary Angioplasty: The New Frontier
The Great Debate: Distal CTEPH – Getting to the Root of the Problem: PTE or BPA? Michael Madani, MD, FACS and Robert Frantz, MD
Technical Considerations and Challenges in BPA Riyaz Bashir, MD
BPA: How Much BPA Is Enough? Targets, Goals, and Limitations Richard Krasuski, MD
BPA After PTE: Whether to Consider, When to Do It Ken Rosenfield, MD
Medical Management in a Non-PTE Candidate Michael Cuttica, MD
Handling Vessel Injury and Hemoptysis After a BPA David Poch, MD
BPA Combined with Medical Management in Inoperable CTEPH Vladimir Lakhter, DO
By the end of the session the participant will be able to:
ACCME Activity #201861290
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.
Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 4.5 contact hours (0.45 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-activity assessment and evaluation. Participants must participate in the entire group of presentations and complete the course evaluation to receive continuing pharmacy education credit.
This is an Application (A)-type activity.
Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.
The CPE statements of credit contain information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
The following individuals have no conflicts of interest to disclose:
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.